SU086, an Inhibitor of HSP90, Impairs Glycolysis and Represents a Treatment Strategy for Advanced Prostate Cancer

The authors demonstrated that SU086 inhibited the growth of prostate cancer cells in vitro, cell-line and patient-derived xenografts in vivo, and ex vivo prostate cancer patient specimens.